FCGR3A and neoplasm: Targeting tumor cells via NK cell-mediated ADCC is promising, as this function appears to be poorly influenced by hypoxia or TAFs, as both hypoxia and TAFs appear to have no influence on the expression and function of CD16 in vitro [178,194,208].